Documentos relacionados

1. Is Intravenously Administered Tolvaptan Mighty Like Triton?
2. A tolvaptan skeptic repents.
3. Much Ado About Something: The Clinical Pattern of Tolvaptan-Associated Liver Injury in Participants With ADPKD.
4. Simple Score to Predict Treatment Response to Low-Dose Tolvaptan in Patients with Heart Failure.
5. Tolvaptan or transplant: why wait?
6. In vitro and in vivo pharmacological profile of OPC-61815, a water-soluble phosphate ester pro-drug of tolvaptan.
7. Tolvaptan induces body fluid loss and subsequent water conservation in normal rats.
8. Vaptans or voluntary increased hydration to protect the kidney: how do they compare?
9. Coping with missing data in phase III pivotal registration trials: Tolvaptan in subjects with kidney disease, a case study.
10. Tolvaptan and Autosomal Dominant Polycystic Kidney Disease.